Oscar Health (NYSE:OSCR) Now Covered by Analysts at Jefferies Financial Group

Research analysts at Jefferies Financial Group assumed coverage on shares of Oscar Health (NYSE:OSCR - Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat reports. The brokerage set an "underperform" rating and a $12.00 price target on the stock. Jefferies Financial Group's price target indicates a potential downside of 20.11% from the stock's current price.

Several other equities research analysts also recently weighed in on OSCR. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and decreased their target price for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler reaffirmed an "overweight" rating and set a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group started coverage on Oscar Health in a report on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price on the stock. Two analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $21.56.

Oscar Health Stock Performance

OSCR traded down $1.53 during trading on Tuesday, hitting $15.02. 4,940,244 shares of the stock were exchanged, compared to its average volume of 3,452,520. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health has a 1-year low of $7.50 and a 1-year high of $23.79. The stock has a fifty day moving average price of $16.80 and a two-hundred day moving average price of $17.77. The firm has a market capitalization of $3.71 billion, a P/E ratio of -259.17 and a beta of 1.64.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. During the same period in the previous year, the firm earned ($0.29) earnings per share. The business's revenue was up 68.3% compared to the same quarter last year. As a group, sell-side analysts predict that Oscar Health will post -0.01 earnings per share for the current year.

Insider Activity at Oscar Health

In related news, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of Oscar Health stock in a transaction dated Tuesday, November 12th. The stock was bought at an average cost of $13.68 per share, for a total transaction of $5,756,803.92. Following the transaction, the director now owns 5,452,081 shares in the company, valued at approximately $74,584,468.08. The trade was a 8.36 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Victoria Baltrus sold 8,078 shares of the company's stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares in the company, valued at approximately $2,640,330.88. This represents a 5.24 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have acquired 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company's stock.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently bought and sold shares of OSCR. Westfield Capital Management Co. LP acquired a new position in Oscar Health during the third quarter worth about $27,452,000. Renaissance Technologies LLC increased its position in Oscar Health by 31.7% during the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock worth $61,478,000 after buying an additional 934,600 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Oscar Health in the second quarter worth $14,716,000. Bank of New York Mellon Corp lifted its position in shares of Oscar Health by 161.4% in the second quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company's stock valued at $22,038,000 after acquiring an additional 860,226 shares in the last quarter. Finally, Soros Fund Management LLC acquired a new stake in shares of Oscar Health during the third quarter valued at $12,726,000. 75.70% of the stock is owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.